Literature DB >> 638616

Prolongation and enhancement of serum methotrexate concentrations by probenecid.

G W Aherne, E Piall, V Marks, G Mould, W F White.   

Abstract

The disappearance of methotrexate (MTX) from the serum after an intravenous bolus injection and intravenous infusion was studied over 24 hours in eight and four patients respectively. Probenecid given at the same time as the bolus injection delayed the disappearance of MTX from the serum and resulted in enhanced concentrations throughout the 24 hours studied. At 24 hours the mean concentration was four times higher than in patients not given probenecid. Overall serum concentrations were even greater than those in patients who had received MTX by intravenous infusion. We suggest that smaller doses of MTX may be given and treatment costs thereby reduced if probenecid is given in addition.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638616      PMCID: PMC1604344          DOI: 10.1136/bmj.1.6120.1097

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  SODIUM AMPICILLIN: ABSORPTION AND EXCRETION OF INTRAMUSCULAR AND INTRAVENOUS DOSES IN NORMAL YOUNG MEN.

Authors:  T C EICKHOFF; J W KISLAK; M FINLAND
Journal:  Am J Med Sci       Date:  1965-02       Impact factor: 2.378

2.  Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.

Authors:  M Homeida; C Roberts; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

3.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Authors:  E S Henderson; R H Adamson; V T Oliverio
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

4.  Pharmacokinetics of methotrexate.

Authors:  D H Huffman; S H Wan; D L Azarnoff; B Hogstraten
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

6.  The renal excretion of indomethacin and its inhibition by probenecid.

Authors:  M D Skeith; P A Simkin; L A Healey
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

7.  Inhibition of renal tubular transport of methotrexate by probenecid.

Authors:  R S Bourke; G Chheda; A Bremer; O Watanabe; D B Tower
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

8.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

Authors:  W R Shapiro; D F Young; B M Mehta
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

9.  Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates.

Authors:  W M Hryniuk; J R Bertino
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Development and application of a radioimmunoassay for methotrexate.

Authors:  G W Aherne; E M Piall; V Marks
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

  10 in total
  26 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.

Authors:  D J Grimes; M R Bowles; J A Buttsworth; D B Thomson; P J Ravenscroft; P F Nixon; R F Whiting; S M Pond
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 4.  Clinically relevant drug-drug interactions in oncology.

Authors:  H L McLeod
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

Review 5.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 6.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

7.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.

Authors:  H Iven; H Brasch; J Engster
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 8.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

9.  The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.